Hormone refractory prostate cancer (HRPC) is the progression of disease in the presence of castrate serum levels of testosterone with a median survival of approximately 1 year.

 
  • 激素難治性前列腺癌(HRPC)是在中位存活時(shí)間約為1年的時(shí)間里出現睪酮的去勢血清水平的疾病的進(jìn)展。
今日熱詞
目錄 附錄 查詞歷史
国内精品美女A∨在线播放xuan